SCHEMBL2411487

SCHEMBL2411487

Cc1cc(O[C@@H]2SC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccnn2-c2ccccc2)cc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
ATM Q13315 1/20 0.35
PTGER1 P34995 1/20 0.35
PDE10A Q9Y233 3/20 0.32
THRB P10828 1/20 0.32
SCN9A Q15858 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSP90AA1 P07900 1/20 0.31
MDM2 Q00987 1/20 0.30
KDM4E B2RXH2 1/20 0.30
PSMD14 O00487 1/20 0.30
LMNA P02545 1/20 0.30
PKM P14618 1/20 0.30
RAB9A P51151 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2411490 1.00 MAPT (0.35) MAPTALDH1A1ATMPTGER1PDE10A
SCHEMBL2417680 0.80 PTGER1 (0.35) MAPTALDH1A1ATMPTGER1PDE10A
SCHEMBL2417678 0.80 PTGER1 (0.35) MAPTALDH1A1ATMPTGER1PDE10A
SCHEMBL2418759 0.77 KDM4E (0.49) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2418762 0.77 KDM4E (0.49) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL1630304 0.73 MAPT (0.54) MAPTALDH1A1ATMPTGER1PDE10A
SCHEMBL2412440 0.65 BRD4 (0.34) MAPTKMT2ALMNA
SCHEMBL2412437 0.65 BRD4 (0.34) MAPTKMT2ALMNA
SCHEMBL2411799 0.64 BRD4 (0.38) ALDH1A1KMT2AMAPK1HSD17B10TDP1
SCHEMBL2411794 0.64 BRD4 (0.38) ALDH1A1KMT2AMAPK1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013010-B2 5-thioxylopyranose compounds LABORATOIRES FOURNIER S.A. (FR) 2011-09-06 US disclosed
US-20090186840-A1 5-Thioxylopyranose Compounds LABORATOIRES FOURNIER S.A (FR) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186840-A1 5-Thioxylopyranose Compounds TPMT, PNPO, CYP3A5 MAPT 4090/4885ALDH1A1 1420/4885ATM 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.